Wellbeing Digital Sciences Inc의 최근 주당순이익은 $로, $의 예상을 .
Wellbeing Digital Sciences Inc KONEF의 지난 분기 매출 실적은 어땠나요?
Wellbeing Digital Sciences Inc의 지난 분기 매출은 $입니다.
Wellbeing Digital Sciences Inc의 매출 추정치는 얼마인가요?
명의 월스트리트 애널리스트에 따르면, Wellbeing Digital Sciences Inc의 매출 추정치는 $에서 $까지입니다.
Wellbeing Digital Sciences Inc의 수익 품질 점수는 얼마인가요?
Wellbeing Digital Sciences Inc의 수익 품질 점수는 B+/55.903446입니다. 이 점수는 수익성, 성장, 현금 창출 및 자본 배분, 레버리지의 네 가지 차원을 기반으로 합니다.
Wellbeing Digital Sciences Inc는 언제 수익을 보고하나요?
Wellbeing Digital Sciences Inc의 다음 수익 보고서는 2022-12-14에 발표될 예정입니다.
Wellbeing Digital Sciences Inc의 예상 수익은 얼마인가요?
월스트리트 애널리스트에 따르면 Wellbeing Digital Sciences Inc의 예상 수익은 $입니다.
Wellbeing Digital Sciences Inc은 수익 기대치를 충족했나요?
Wellbeing Digital Sciences Inc의 최근 수익은 $로, 기대치를 .
주요 통계
이전 종가
$0
시가
$0
일일 범위
$0 - $0
52주 범위
$0 - $0
거래량
360
평균 거래량
1.0K
배당수익률
--
EPS(TTM)
-0.21
시가총액
$1.2K
KONEF란 무엇인가요?
Wellbeing Digital Sciences, Inc. is a healthcare company, which engages in the development and implementation of innovative clinical treatment solutions, including psychedelic medicine and digital therapeutics, as supported by clinical research. The company is headquartered in London, British Columbia. The company went IPO on 2021-01-27. The firm is focused on the development and implementation of clinical treatment solutions, including psychedelic medicine and digital therapeutics, as supported by clinical research. The company operates through three segments: Wellbeing & IRP; KGK Science and Mindscape. The company operates medical clinics across North America to help its patients access plant-based medicines, psychedelics, and other forms of mental health care, all of which have the potential to heal them of their physical and/or emotional pain. Its subsidiaries include Mindscape Ketamine & Infusions Therapy LLC, KGK Science Inc. and Integrated Rehab and Performance Ltd. The company is supported by a network of North American clinics that provide therapies and other types of treatment to patients, as well as through a contract research organization that offers clinical trials services to clients pursuing drug development.